Five-year results of short-course brentuximab vedotin combined with chemotherapy and radiation in early stage, unfavorable Hodgkin lymphoma.

Authors

Robert Stuver, Esther Drill, Laure Michaud, Carla Casulo, Ranjana H Advani, Elizabeth L Budde, Paul M Barr, Connie Lee Batlevi, Philip C Caron, Louis S Constine, Pamela Drullinsky, Savita V Dandapani, Jonathan W Friedberg, Clare Grieve, Paul A Hamlin, Richard Hoppe, Steven M Horwitz, Niloufer Khan, Ashlee Joseph, Matthew J Matasar, Ariela Noy, Maria Lia Palomba, Heiko Schöder, David J Sraus, Shreya Vemuri, Joachim Yahalom, Joanna C Yang, Andrew D Zelenetz, Craig H Moskowitz, Anita Kumar, Alison J Moskowitz

Published in

Haematologica. Oct 01, 2026. Epub Oct 01, 2026.

Abstract

Not available.

PMID:
42817844
Bibliographic data and abstract were imported from PubMed on 01 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.